12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Company News  |  Deals

Arrow Therapeutics, Virogen deal

The companies will develop therapeutics to treat respiratory syncytial virus (RSV). Arrow will provide its compound library to...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >